WVE. They are about to release data on their Huntington disease program. The stock cratered -60% a few days ago after they announced discontinuation for DMD program in earlier phase. The company is working on the space of ASOs. Currently is at 52wl. I like to search for "falling angels" but this one seems to risky. Anyone has any insight? comments on it?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.